---
aliases: /news/4-recent-drug-approvals
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - 4 Recent Drug Approvals
categories:
  - 'Medical Subject Headings (MeSH): Drug Development'
  - 'U.S. Food and Drug Administration (FDA): Drugs'
categorySlug:
  - 'medical subject headings (mesh): drug development'
  - 'u.s. food and drug administration (fda): drugs'
categoryUrl:
  - topic/medical-subject-headings-mesh-drug-development
  - topic/u-s-food-and-drug-administration-fda-drugs
categoryLabel:
  - Drug Development
  - Drugs
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2021-12-30'
description: >-
  Here are four FDA drug or treatment approvals Becker's has covered since Nov.
  15, starting with the most recent:Here are four FDA drug or treatment
  approvals Becker's has covered since Nov. 15, starti
favIconImage: null
featuredImage:
  alt: 4 Recent Drug Approvals
  format: JPEG
  href: b2120cc5-c040-59ce-a050-3dad93773aec-featuredImage.jpeg
  size:
    - 300
    - 400
  valid: true
  workPackage: 10587
  wpAttachment:
    fileName: Curated_Featured_Image.jpg
    link: /api/v3/attachments/20280/content
featuredPdf: null
htmlMetaData:
  author: Erica Carbajal
  description: >-
    Here are four FDA drug or treatment approvals Becker's has covered since
    Nov. 15, starting with the most recent:
  generator: null
  viewport: 'width=device-width, initial-scale=1'
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: >-
    Here are four FDA drug or treatment approvals Becker's has covered since
    Nov. 15, starting with the most recent:
  ogimage: null
  ogsite_name: null
  ogtitle: 4 recent drug approvals
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: >-
    pharmacy, drug approval, FDA, treatment, pharmacist, approvals, starting
    with the most recent, covered, nov, fda
id: 10587
identifier: News
lastMod: '2021-12-30T15:50:19.827917Z'
link:
  brand: beckershospitalreview.com
  href: >-
    https://www.beckershospitalreview.com/pharmacy/4-recent-drug-approvals-2.html
  original: >-
    https://www.beckershospitalreview.com/pharmacy/4-recent-drug-approvals-2.html
href: 'https://www.beckershospitalreview.com/pharmacy/4-recent-drug-approvals-2.html'
original: 'https://www.beckershospitalreview.com/pharmacy/4-recent-drug-approvals-2.html'
mastHead: NEWS
mdName: b2120cc5-c040-59ce-a050-3dad93773aec.md
openGraphMetaData:
  ogdescription: >-
    Here are four FDA drug or treatment approvals Becker's has covered since
    Nov. 15, starting with the most recent:
  ogtitle: 4 recent drug approvals
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.beckershospitalreview.com/pharmacy/4-recent-drug-approvals-2.html
  medigyTopics:
    - 'Medical Subject Headings (MeSH): Drug Development'
    - 'U.S. Food and Drug Administration (FDA): Drugs'
  sourceUrl: >-
    https://www.beckershospitalreview.com/pharmacy/4-recent-drug-approvals-2.html
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: beckershospitalreview-4-recent-drug-approvals
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: 4 Recent Drug Approvals
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: Voraxaze®
    permalink: /offering/voraxaze-r
    categories:
      - 'Medigy: Medication Management'
      - 'U.S. Food and Drug Administration (FDA): Drugs'
    offeringId: 6916
  - label: Varithena®
    permalink: /offering/varithena-r
    categories:
      - 'Healthcare IT News: Disease Prevention'
      - 'Medigy: Life Sciences Tools'
      - 'U.S. Food and Drug Administration (FDA): Drugs'
      - 'Medigy: Medication Management'
    offeringId: 6892
  - label: DigiFab® Digoxin Immune Fab
    permalink: /offering/digifab-r-digoxin-immune-fab
    categories:
      - 'U.S. Food and Drug Administration (FDA): Drugs'
    offeringId: 5766
twitterMetaData:
  twittercard: null
  twitterdescription: >-
    Here are four FDA drug or treatment approvals Becker's has covered since
    Nov. 15, starting with the most recent:
  twittertitle: 4 recent drug approvals
  twitterimage: 'https://www.beckershospitalreview.com/images/channels/pharmacy/2.jpg'
  twitterurl: null
---
<p>Here are four FDA drug or treatment approvals Becker's has covered since Nov. 15, starting with the most recent:</p><p>Here are four FDA drug or treatment approvals <i>Becker's</i> has covered since Nov. 15, starting with the most recent:</p><p>1.&nbsp;<a href="https://www.beckershospitalreview.com/pharmacy/fda-approves-1st-injectable-hiv-preventive.html"><strong>Apretude</strong></a><strong> </strong>— Apretude was approved as the first injectable treatment for HIV preexposure prevention, or PrEP.&nbsp;</p><p>2.&nbsp;<a href="https://www.beckershospitalreview.com/pharmacy/fda-approves-imaging-drug-for-ovarian-cancer-lesions.html"><strong>Pafolacianine</strong></a><strong> </strong>— Pafolacianine, which goes by the brand name Cytalux, is an imaging drug that has been approved to help surgeons better identify cancerous ovarian tissue when operating.&nbsp;</p><p>3.&nbsp;<a href="https://www.beckershospitalreview.com/pharmacy/fda-approves-rare-blood-disease-treatment.html"><strong>Besremi</strong></a><strong> </strong>— PharmaEssentia Corp.'s Besremi has been approved for the treatment of a rare blood disease called polycythemia vera, which affects about 6,200 people in the U.S. annually.&nbsp;</p><p>4.&nbsp;<a href="https://www.beckershospitalreview.com/pharmacy/fda-approves-first-drug-to-treat-short-stature-caused-by-most-common-form-of-dwarfism.html"><strong>Voxzogo</strong></a><strong> </strong>— BioMarin's Voxzogo has been approved as the first drug designed to treat short stature caused by achondroplasia, the most common form of dwarfism.&nbsp;</p><p>The FDA approved 46 new drugs in 2021, including <a href="https://www.beckershospitalreview.com/pharmacy/16-cancer-drugs-approved-in-2021.html">16 cancer drugs</a>. To view the full list, click <a href="https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021">here</a>.&nbsp;<br>&nbsp;</p>